Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

About 80 million Americans fill prescriptions each year for medications to treat new instances of moderate to severe pain, ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to local medical professionals. "I think it could be a potentially ...

Vertex Pharmaceuticals ( VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and ...

Portland Mayor Keith Wilson announced today that the city will use about $1.5 million in opioid settlement funds to create the new recovery shelter beds.

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

A new painkiller was approved by the Food and Drug Administration (FDA) on Thursday, and is one step closer to making its way ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

Americans consume more illicit drugs per capita than anyone else in the world; about 6% of the U.S. population uses them ...

While it's next to impossible to know how many opioids entered the state illegally in 2023, we do know that just under 1.7 ...